301 results on '"Kent, Brian D."'
Search Results
2. Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis
3. COVID-19 and Obstructive Sleep Apnoea
4. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
5. Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease
6. Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial
7. Emergency medical admissions and COVID-19: impact on 30-day mortality and hospital length of stay
8. COVID-19 and Obstructive Sleep Apnoea
9. Questionnaires in respiratory sleep medicine
10. Clinical examination
11. Sleep medicine and Coronavirus disease 2019
12. Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management
13. Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization
14. Differential diagnosis of pulmonary eosinophilia
15. Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma
16. Adherence to wakefulness promoting medication in patients with narcolepsy
17. Continuous positive airway pressure versus standard care for the treatment of people with mild obstructive sleep apnoea (MERGE): a multicentre, randomised controlled trial
18. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
19. Sleep medicine and coronavirus disease 2019
20. P2 Intravenous ferric carboxymaltose for the treatment of refractory restless leg syndrome
21. Treatment of obstructive sleep apnoea in patients with interstitial lung disease improves quality of life and survival
22. Late Breaking Abstract - SHAMAL: reduction of maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab: a randomised phase 4 study
23. The changing face of the modern respiratory clinician
24. The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma
25. Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice
26. Catathrenia, a REM predominant disorder of arousal?
27. Sleep and interstitial lung disease
28. Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial
29. Sleep and asthma
30. Pulmonary vascular disease for the general respiratory clinician
31. Diabetes Mellitus Prevalence and Control in Sleep-Disordered Breathing: The European Sleep Apnea Cohort (ESADA) Study
32. What we do and do not know about managing respiratory disease in pregnancy
33. Infectious disease in respiratory medicine
34. Genetics of Cardiovascular Consequences of Obstructive Sleep Apnea Syndrome
35. Targeted therapy in respiratory disease
36. Sleep-stage sequencing of sleep-onset REM periods in MSLT predicts treatment response in patients with narcolepsy
37. The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma
38. Emergency medical admissions and COVID-19: impact on 30-day mortality and hospital length of stay
39. A Brief History of Fluid and Sleep
40. Asthma and Cystic Fibrosis: A Tangled Web
41. Practical Applications of FeNO Measurement and Inhaler Monitoring Technologies in the Management of Difficult Asthma
42. Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy
43. Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
44. Asthma admissions, smoking bans and administrative databases
45. Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database
46. Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma
47. Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma
48. Questionnaires on sleep
49. Acute Pulmonary Admissions Following Implementation of a National Workplace Smoking Ban
50. Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.